ARCHIVES

IND-Exempt Trials May Need Special Review, HCFA Says.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

Bennett, Turner & Coleman Law Firm To Merge With Ropes & Gray

July 5, 2002

Carter Request Only $878.8 Million For NCI

January 27, 1978

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

Chemoprevention Clinical Trial RFA Being Developed For January Concept Review, Along With “Bridge” RFA

November 27, 1981

In Breif: Baltimore Developer Donates $10 Million To Univ. of Maryland Medical System

July 19, 1996